Spontaneous bladder perforations following augmentation cystoplasty in children: Commentary

Nature Clinical Practice Urology

Volumn 3, Issue 11, 2006, Pages 584-585

  Guven, Ahmet ^a   Onal, Bulent ^b   Kogan, Barry A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

OXYBUTYNIN;

BLADDER CATHETERIZATION; BLADDER DYSFUNCTION; BLADDER PERFORATION; BLADDER RECONSTRUCTION; COHORT ANALYSIS; DRUG RESPONSE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; ILEUM; INCIDENCE; MEDICAL RECORD REVIEW; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; SIGMOID; STATISTICAL SIGNIFICANCE; SURGICAL RISK; SURGICAL TECHNIQUE; UNITED STATES;

CHILD; HUMANS; URINARY BLADDER; URINARY BLADDER, NEUROGENIC; UROLOGIC SURGICAL PROCEDURES;

EID: 33750704914     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0608     Document Type: Short Survey

References (5)

1. Diokno AC and Lapides J (1972) Oxybutynin: A new drug with analgesic and anticholinergic properties. J Urol 108: 307-309
2. Lapides J et al. (1972) Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107: 458-461
3. Diokno AC et al. (1976) New approach to myelodysplasia. J Urol 116: 771-772
4. Baskin LS et al. (1990) Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation. Br J Urol 66: 532-534
5. Wu HY et al. (1997) Neurogenic bladder dysfunction due to myelomeningocele: Neonatal versus childhood treatment. J Urol 157: 2295-2297